Novel analysis of 3-y results from the pivotal EPCORE NHL-1 study: Outcomes in patients (pts) with relapsed/refractory large B-cell lymphoma (R/R LBCL) and complete response (CR) at 2 y with epcoritamab (epcor) monotherapy.
Authors
Barbara D’Angelo Månsson
Michael Roost Clausen (ORCID: https://orcid.org/0000-0003-3218-3633)
Mohammad Atiya
Tatyana A. Feldman (ORCID: https://orcid.org/0000-0002-4458-2896)
Kim Linton (ORCID: https://orcid.org/0000-0002-3294-1548)
Novel analysis of 3-y results from the pivotal EPCORE NHL-1 study: Outcomes in patients (pts) with relapsed/refractory large B-cell lymphoma (R/R LBCL) and complete response (CR) at 2 y with epcoritamab (epcor) monotherapy.
Barbara D’Angelo Månsson, Michael Roost Clausen, Mohammad Atiya, Tatyana A. Feldman et al.
Local Database Links
1 links
Journal
Journal of Clinical Oncology
Topics
Lung Cancer Treatments and Mutations
article
Novel analysis of 3-y results from the pivotal EPCORE NHL-1 study: Outcomes in patients (pts) with relapsed/refractory large B-cell lymphoma (R/R LBCL) and complete response (CR) at 2 y with epcoritamab (epcor) monotherapy.
Barbara D’Angelo Månsson, Michael Roost Clausen, Mohammad Atiya, Tatyana A. Feldman, Kim Linton, Catherine Thiéblemont, David Soong, Yasmin H. Karimi, Christian Winther Eskelund, David Cunningham, Tycel Phillips, Martin Hutchings, Chan Yoon Cheah, Won Seog Kim, Hervé Ghesquières, Julie M. Vose, Umar Farooq, Wojciech J. Jurczak, Milan S. Geybels, Pegah Jafarinasabian
article en
Abstract
No abstract available for this paper.
Publication Tag
Journal of Clinical OncologyVol. 43(16_suppl)
Institutions
University of Copenhagen (DK), University of Iowa (US), Royal Marsden NHS Foundation Trust (GB), The University of Western Australia (AU), Université Paris Cité (FR), Genmab (United States) (US), University of Michigan (US), Samsung Medical Center (KR), Sir Charles Gairdner Hospital (AU), Rigshospitalet (DK), University of Manchester (GB), AbbVie (United States) (US), Vejle Sygehus (DK), Assistance Publique – Hôpitaux de Paris (FR), Hospices Civils de Lyon (FR), Hôpital Lyon Sud (FR), Michigan Center for Translational Pathology (US), The Christie NHS Foundation Trust (GB), Hôpital Saint-Louis (FR), Hackensack Meridian Health (US), Genmab (Denmark) (DK), University of Nebraska Medical Center (US)